Terms: = Prostate cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394
37 results:
1. Liquid Biopsies for Early Response Evaluation of Radium-223 in Metastatic prostate cancer.
de Jong AC; Isebia KT; Ling SW; de Weerd V; Van NM; Kraan J; Martens JWM; Mehra N; Hamberg P; Lolkema MP; de Wit R; van der Veldt AAM; Wilting SM
JCO Precis Oncol; 2023 Sep; 7():e2300156. PubMed ID: 38061007
[TBL] [Abstract] [Full Text] [Related]
2. Early response monitoring during [
Neubauer MC; Nicolas GP; Bauman A; Fani M; Nitzsche E; Afshar-Oromieh A; Forrer F; Rentsch C; Stenner F; Templeton A; Schäfer N; Wild D; Chirindel A;
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1185-1193. PubMed ID: 38038755
[TBL] [Abstract] [Full Text] [Related]
3. Optical genome mapping reveals balanced and unbalanced genetic changes associated with tumor-forming potential in an early-stage prostate cancer epithelial subline (M2205).
Paulraj P; Barrie E; Jackson-Cook C
Mol Genet Genomic Med; 2024 Jan; 12(1):e2307. PubMed ID: 37902189
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [
Kendrick J; Francis RJ; Hassan GM; Rowshanfarzad P; Ong JS; McCarthy M; Alexander S; Ebert MA
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4077-4086. PubMed ID: 37550494
[TBL] [Abstract] [Full Text] [Related]
5.
de Jong AC; Segbers M; Ling SW; Graven LH; Mehra N; Hamberg P; Brabander T; de Wit R; van der Veldt AAM
J Nucl Med; 2023 Oct; 64(10):1556-1562. PubMed ID: 37536738
[TBL] [Abstract] [Full Text] [Related]
6. Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant prostate cancer.
Gafita A; Djaileb L; Rauscher I; Fendler WP; Hadaschik B; Rowe SP; Herrmann K; Calais J; Rettig M; Eiber M; Weber M; Benz MR; Farolfi A
Radiology; 2023 Jul; 308(1):e222148. PubMed ID: 37432081
[TBL] [Abstract] [Full Text] [Related]
7. Role of volumetric parameters obtained from
Güzel Y; Kömek H; Can C; Kaplan İ; Akdeniz N; Kepenek F; Gündoğan C
Ann Nucl Med; 2023 Sep; 37(9):517-527. PubMed ID: 37332068
[TBL] [Abstract] [Full Text] [Related]
8. Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts.
Grahovac M; Spielvogel CP; Krajnc D; Ecsedi B; Traub-Weidinger T; Rasul S; Kluge K; Zhao M; Li X; Hacker M; Haug A; Papp L
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1607-1620. PubMed ID: 36738311
[TBL] [Abstract] [Full Text] [Related]
9.
John N; Pathmanandavel S; Crumbaker M; Counter W; Ho B; Yam AO; Wilson P; Niman R; Ayers M; Poole A; Hickey A; Agrawal S; Perkins G; Kallinen A; Eslick E; Stockler MR; Joshua AM; Nguyen A; Emmett L
J Nucl Med; 2023 Mar; 64(3):410-415. PubMed ID: 36215568
[No Abstract] [Full Text] [Related]
10. Evaluation of
Pathmanandavel S; Crumbaker M; Ho B; Yam AO; Wilson P; Niman R; Ayers M; Sharma S; Hickey A; Eu P; Stockler M; Martin AJ; Joshua AM; Nguyen A; Emmett L
J Nucl Med; 2023 Feb; 64(2):221-226. PubMed ID: 36008120
[No Abstract] [Full Text] [Related]
11. Reconstructing tumor clonal lineage trees incorporating single-nucleotide variants, copy number alterations and structural variations.
Fu X; Lei H; Tao Y; Schwartz R
Bioinformatics; 2022 Jun; 38(Suppl 1):i125-i133. PubMed ID: 35758777
[TBL] [Abstract] [Full Text] [Related]
12. The Prognostic Value of Posttreatment
Pathmanandavel S; Crumbaker M; Nguyen A; Yam AO; Wilson P; Niman R; Ayers M; Sharma S; Eu P; Martin AJ; Stockler MR; Joshua AM; Emmett L
J Nucl Med; 2023 Jan; 64(1):69-74. PubMed ID: 35738906
[No Abstract] [Full Text] [Related]
13. Deviation from consensus contouring guidelines predicts inferior local control after spine stereotactic body radiotherapy.
Chen X; LeCompte MC; Gui C; Huang E; Khan MA; Hu C; Sciubba DM; Kleinberg LR; Lo SL; Redmond KJ
Radiother Oncol; 2022 Aug; 173():215-222. PubMed ID: 35667571
[TBL] [Abstract] [Full Text] [Related]
14. An analysis of health-related quality of life in the phase III PROSELICA and FIRSTANA studies assessing cabazitaxel in patients with metastatic castration-resistant prostate cancer.
Thiery-Vuillemin A; Fizazi K; Sartor O; Oudard S; Bury D; Thangavelu K; Ozatilgan A; Poole EM; Eisenberger M; de Bono J
ESMO Open; 2021 Apr; 6(2):100089. PubMed ID: 33740734
[TBL] [Abstract] [Full Text] [Related]
15. 8-Epi-xanthatin induces the apoptosis of DU145 prostate carcinoma cells through signal transducer and activator of transcription 3 inhibition and reactive oxygen species generation.
Lee YJ; Choi J; Yoon YJ; Sim Y; Ryu HW; Oh SR; Kim DY; Hwang J; Chi SW; Han DC; Kwon BM
Phytother Res; 2021 Mar; 35(3):1508-1520. PubMed ID: 33164240
[TBL] [Abstract] [Full Text] [Related]
16. Molecular analysis of circulating tumor cells of metastatic castration-resistant prostate cancer Patients receiving
Kessel K; Seifert R; Weckesser M; Roll W; Humberg V; Schlack K; Bögemann M; Bernemann C; Rahbar K
Theranostics; 2020; 10(17):7645-7655. PubMed ID: 32685010
[No Abstract] [Full Text] [Related]
17. Repeatability of Quantitative
Jansen BHE; Cysouw MCF; Vis AN; van Moorselaar RJA; Voortman J; Bodar YJL; Schober PR; Hendrikse NH; Hoekstra OS; Boellaard R; Oprea-Lager DE
J Nucl Med; 2020 Sep; 61(9):1320-1325. PubMed ID: 31924729
[TBL] [Abstract] [Full Text] [Related]
18. Response assessment using [
Grubmüller B; Rasul S; Baltzer P; Fajkovic H; D'Andrea D; Berndl F; Maj-Hes A; Grubmüller KH; Mitterhauser M; Wadsak W; Pfaff S; Shariat SF; Hacker M; Kramer G; Hartenbach M
Prostate; 2020 Jan; 80(1):74-82. PubMed ID: 31614001
[TBL] [Abstract] [Full Text] [Related]
19. In Organ-confined prostate cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence.
Ito Y; Vertosick EA; Sjoberg DD; Vickers AJ; Al-Ahmadie HA; Chen YB; Gopalan A; Sirintrapun SJ; Tickoo SK; Eastham JA; Scardino PT; Reuter VE; Fine SW
Am J Surg Pathol; 2019 Aug; 43(8):1061-1065. PubMed ID: 31107718
[TBL] [Abstract] [Full Text] [Related]
20. Response assessment using
Grubmüller B; Senn D; Kramer G; Baltzer P; D'Andrea D; Grubmüller KH; Mitterhauser M; Eidherr H; Haug AR; Wadsak W; Pfaff S; Shariat SF; Hacker M; Hartenbach M
Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1063-1072. PubMed ID: 30569186
[TBL] [Abstract] [Full Text] [Related]
[Next]